Cargando…

Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma

This protocol provides the steps required for the establishment of patient-derived xenograft (PDX) tumors for head and neck squamous cell carcinomas (HNSCCs) and their utility in examining drug responses. PDXs recapitulate the heterogeneity observed in the corresponding human tumors, which makes the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karamboulas, Christina, Meens, Jalna, Ailles, Laurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580210/ https://www.ncbi.nlm.nih.gov/pubmed/33111077 http://dx.doi.org/10.1016/j.xpro.2020.100024

Ejemplares similares

Cancer stem cells in head and neck squamous cell carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2013)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

Dose predictions for [(177)Lu]Lu-DOTA-panitumumab F(ab′)(2) in NRG mice with HNSCC patient-derived tumour xenografts based on [(64)Cu]Cu-DOTA-panitumumab F(ab′)(2) – implications for a PET theranostic strategy
por: Ku, Anthony, et al.
Publicado: (2021)

TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
por: Ruicci, Kara M., et al.
Publicado: (2020)

Extracellular Heparan 6-O-Endosulfatases SULF1 and SULF2 in Head and Neck Squamous Cell Carcinoma and Other Malignancies
por: Yang, Yang, et al.
Publicado: (2022)

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
por: Murillo-Sauca, Oihana, et al.
Publicado: (2014)

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies
por: Perréard, Marion, et al.
Publicado: (2023)

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
por: Kang, Han Na, et al.
Publicado: (2020)

An Improved Protocol for Establishment of AML Patient-Derived Xenograft Models
por: Hassan, Nunki, et al.
Publicado: (2020)

Protocol for Bulk-ATAC sequencing in head and neck squamous cell carcinoma
por: Chen, Nana, et al.
Publicado: (2023)

Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21
por: Hussain, Ali, et al.
Publicado: (2020)

Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib
por: Hu, Fangling, et al.
Publicado: (2021)

Influence of Handling Conditions on the Establishment and Propagation of Head and Neck Cancer Patient Derived Xenografts
por: Stein, Andrew P., et al.
Publicado: (2014)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model
por: Chen, Chi-Yuan, et al.
Publicado: (2009)

Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
por: Harms, Julia K., et al.
Publicado: (2019)

Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients
por: Abel, Lindsey, et al.
Publicado: (2021)

Establishment and Identification of Patient-Derived Xenograft Model for Oral Squamous Cell Carcinoma
por: He, Fei, et al.
Publicado: (2022)

Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma
por: Bai, Aiping, et al.
Publicado: (2019)

Heparan-6-O-Endosulfatase 2 Promotes Invasiveness of Head and Neck Squamous Carcinoma Cell Lines in Co-Cultures with Cancer-Associated Fibroblasts
por: Mukherjee, Pritha, et al.
Publicado: (2023)

Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma
por: Gedye, Craig, et al.
Publicado: (2016)

Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
por: Huizing, Fokko J., et al.
Publicado: (2018)

High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
por: Ghasemi, Farhad, et al.
Publicado: (2018)

Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000
por: Ness, Andrew Robert, et al.
Publicado: (2014)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
por: Stanton, P., et al.
Publicado: (1994)

Xenograft models of head and neck cancers
por: Sano, Daisuke, et al.
Publicado: (2009)

Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
por: Gamboa, Christian Moya, et al.
Publicado: (2021)

Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
por: Lee, Rex H., et al.
Publicado: (2023)

Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma
por: Choonoo, Gabrielle, et al.
Publicado: (2019)

The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells
por: Elliott, Bruce E, et al.
Publicado: (2005)

A Patient-Derived Xenograft Model of Glioblastoma
por: Chokshi, Chirayu R., et al.
Publicado: (2020)

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck.
por: Easty, D. M., et al.
Publicado: (1981)

Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC)
por: Katase, Naoki, et al.
Publicado: (2022)

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2017)

Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts
por: Hennessey, Patrick T., et al.
Publicado: (2011)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_195r6ols7riuik7febi67l8h8l